Paraneoplastic syndromes. Hyperadrenocorticism and ACTH-releasing factor.
D000236:Adenoma / Q000503:physiopathology; D007516:Adenoma, Islet Cell / Q000503:physiopathology; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000032:analysis; D000368:Aged; D000596:Amino Acids / Q000032:analysis; D001681:Biological Assay; D001984:Bronchial Neoplasms / Q000503:physiopathology; D002276:Carcinoid Tumor / Q000503:physiopathology; D018288:Carcinoma, Small Cell / Q000503:physiopathology; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism*; D005260:Female; D006729:Hormones, Ectopic / Q000378:metabolism*; D006801:Humans; D008175:Lung Neoplasms / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000503:physiopathology; D009384:Paraneoplastic Endocrine Syndromes; D010455:Peptides / Q000032:analysis; D013945:Thymoma / Q000503:physiopathology; D013953:Thymus Neoplasms / Q000503:physiopathology
D000596:Amino Acids; D006729:Hormones, Ectopic; D010455:Peptides; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone